Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy

Serum CrossLaps is a new assay for measuring carboxy-terminal collagen crosslinks (CTX) in serum. This measurement is reported to be more specific to bone resorption than other measurements. However, the utility of this and other markers in monitoring patients on antiresorptive therapy depends on ho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Calcified tissue international 2000-02, Vol.66 (2), p.100-103
Hauptverfasser:	Rosen, H N, Moses, A C, Garber, J, Iloputaife, I D, Ross, D S, Lee, S L, Greenspan, S L
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - therapeutic use Biomarkers - blood Bone Density - drug effects Bone Resorption - blood Bone Resorption - chemically induced Bone Resorption - drug therapy Collagen - blood Collagen Type I Diphosphonates - therapeutic use Female Humans Male Pamidronate Peptides - blood Thyroid Hormones - adverse effects Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!